2 unknown, 1 completed, 1 not yet recruiting, 1 recruiting. 2 Phase 4, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Unknown 2 |
| Not applicable | 1 | Not yet recruiting 1 |
Follow Depressive Syndrome: new trials by email Literature Review of Depressive Syndrome trials Research Report on Depressive Syndrome
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effectiveness of Clustered Versus Tapered Repetitive Transcranial Magnetic Stimulation (rTMS) as Maintenance Therapy Following Successful Acute rTMS Treatment in Patients With Depressive Syndrome Repetitive Transcranial Magnetic Stimulation (rTMS), Theta Burst Stimulation - Major Depressive Disorder (MDD), Depressive Episodes | Not applicable | Not yet recruiting | Technical University of Munich | 100 | 2026-08-01 | 2026-07-27 |
| Comprehensive Geriatric Assessment in Kidney Transplantation Functional geriatric assessment - Kidney Transplant; Complications, Frailty Syndrome | Recruiting | Institute for Clinical and Experimental Medicine | 1000 | 2020-01-02 | 2023-10-27 | |
| Osteoporosis Treatment in Post-menopausal Women Raloxifene, Alendronate - Depressive Syndrome | Phase 4 | Unknown | Taichung Veterans General Hospital | 500 | 2017-01-01 | 2019-01-14 |
| Study of Escitalopram Versus Placebo in the Treatment of Depressive Syndrome in Alzheimer's Disease, Vascular Dementia, and Mixed Vascular and Alzheimer's Dementia Escitalopram - Depressive Syndrome | Phase 4 | Unknown | Sheba Medical Center | 40 | 2004-12-01 | 2006-08-29 |
| Study Evaluating Venlafaxine Extended Release in Elderly Depressed Patients Depressive Syndrome, Anxiety | Completed | Wyeth is now a wholly owned subsidiary of Pfizer | 59 | 2004-07-01 | 2009-09-01 |
Depressive Disorder (5) · Depression (3) · Alzheimer Disease (1) · Anxiety Disorders (1) · Dementia (1) · Depressive Disorder, Major (1) · Frailty (1) · Osteoporosis (1)
Mental Disorders (5) · Mood Disorders (5) · Behavior (3) · Behavioral Symptoms (3) · Bone Diseases (1) · Bone Diseases, Metabolic (1) · Brain Diseases (1) · Central Nervous System Diseases (1) · Metabolic Diseases (1) · Musculoskeletal Diseases (1) · Nervous System Diseases (1) · Neurocognitive Disorders (1) · Neurodegenerative Diseases (1) · Nutritional and Metabolic Diseases (1) · Pathologic Processes (1)
Alendronate (1) · Escitalopram (1) · Raloxifene Hydrochloride (1) · Transcranial Magnetic Stimulation (1)
Institute for Clinical and Experimental Medicine (1) · Sheba Medical Center (1) · Taichung Veterans General Hospital (1) · Technical University of Munich (1) · Wyeth is now a wholly owned subsidiary of Pfizer (1)
Czechia (1) · Germany (1) · Israel (1) · Taiwan (1)
Anna Sverdlik, MD (1) · Hana Vankova, MD,PhD (1) · Silvie Rajnochova Bloudickova, MD,PhD (1)
PMID 25336440, PMID 26997416, PMID 30506632, PMID 30890577, PMID 8105269